Skip to main content
Top
Published in: BMC Immunology 1/2018

Open Access 01-12-2018 | Research article

Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda

Authors: Kenneth Musinguzi, Andrew Obuku, Noeline Nakasujja, Harriet Birabwa, Juliet Nakku, Jonathan Levin, Eugene Kinyanda

Published in: BMC Immunology | Issue 1/2018

Login to get access

Abstract

Background

Major depressive disorder (MDD) is a common psychiatric complication of HIV/AIDS. While considerable research has been undertaken to understand the psychosocial risk factors of MDD, there is a paucity of data on its biological risk factors including immunological factors. To address this we undertook a study to investigate the association between MDD and pro-inflammatory cytokines and acute phase proteins among persons living with HIV/AIDS (PLWHA) in Uganda. We collected clinical and laboratory data on 201 PLWHA attending two HIV clinics in central and southwestern Uganda. Clinical data included DSM-IV based MDD diagnosis, while laboratory data included the concentrations of IL-6, TNF-α and CRP measured using ELISA. Multiple logistic linear regression analysis was used to determine which proteins were independently significantly associated with MDD controlling for study site, sex, age and highest educational attainment.

Results

The prevalence of MDD was 62/201 (30.8%). Adjusting for confounders, the odds of MDD increased with increasing levels of IL-6 [each unit increase in IL-6 titres was associated with an aOR = 0.98 (95% CI, 0.97–0.99); p < 0.001]. Participants with low levels of TNF-α were at reduced risk of MDD compared to participants with no TNF-α [those with a TNF-α of 1- <50 pg/ml titres had an aOR = 0.35(95% CI,0.10–1.16)], but as the level of TNF-α increased, the risk of MDD increased, and in particular participants with high levels of TNF-α (of 500 or above) were at a significantly increased risk of MDD [e.g. those with a TNF-α of 500- < 1000 pg/ml titres had an aOR = 3.98 (95% CI,1.29–12.33)] compared to participants with no TNF-α. There was no evidence that MDD was associated with the level of CRP titres [aOR = 0.95 (0.78–1.15); p = 0.60)].

Conclusion

In this study, the pro-inflammatory proteins IL-6 and TNF-α were significantly associated with MDD, while CRP was not.
Literature
3.
go back to reference Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch J, Bing EG, et al. Depressive symptoms over the course of HIV infection before AIDS. Soc Psychiatry Psychiatr Epidemiol. 1996;31(3–4):212–9.CrossRefPubMed Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch J, Bing EG, et al. Depressive symptoms over the course of HIV infection before AIDS. Soc Psychiatry Psychiatr Epidemiol. 1996;31(3–4):212–9.CrossRefPubMed
4.
go back to reference Perry S, Jacobsberg LB, Fishman B, Frances A, Bobo J, Jacobsberg BK. Psychiatric diagnosis before serological testing for the human immunodeficiency virus. Am J Psychiatry. 1990;147(1):89–93.CrossRefPubMed Perry S, Jacobsberg LB, Fishman B, Frances A, Bobo J, Jacobsberg BK. Psychiatric diagnosis before serological testing for the human immunodeficiency virus. Am J Psychiatry. 1990;147(1):89–93.CrossRefPubMed
5.
go back to reference Gorman JM, Kertzner R, Todak G, Goetz RR, Williams JB, Rabkin J, et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. I. Overview of study design. Arch Gen Psychiatry. 1991;48(2):120–3.CrossRefPubMed Gorman JM, Kertzner R, Todak G, Goetz RR, Williams JB, Rabkin J, et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. I. Overview of study design. Arch Gen Psychiatry. 1991;48(2):120–3.CrossRefPubMed
6.
go back to reference Seth R, Granville-Grossman K, Goldmeier D, Lynch S. Psychiatric illnesses in patients with HIV infection and AIDS referred to the liaison psychiatrist. Br J Psychiatry. 1991;159:347–50.CrossRefPubMed Seth R, Granville-Grossman K, Goldmeier D, Lynch S. Psychiatric illnesses in patients with HIV infection and AIDS referred to the liaison psychiatrist. Br J Psychiatry. 1991;159:347–50.CrossRefPubMed
7.
go back to reference Hoover DR, Saah A, Bacellar H, Murphy R, Visscher B, Metz S, et al. The progression of untreated HIV-1 infection prior to AIDS. Am J Public Health. 1992;82(11):1538–41.CrossRefPubMedPubMedCentral Hoover DR, Saah A, Bacellar H, Murphy R, Visscher B, Metz S, et al. The progression of untreated HIV-1 infection prior to AIDS. Am J Public Health. 1992;82(11):1538–41.CrossRefPubMedPubMedCentral
8.
go back to reference Kinyanda E, Nakasujja N, Levin J, Birabwa H, Mpango R, Grosskurth H, et al. Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord. 2017;212:117–27.CrossRefPubMed Kinyanda E, Nakasujja N, Levin J, Birabwa H, Mpango R, Grosskurth H, et al. Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord. 2017;212:117–27.CrossRefPubMed
9.
go back to reference Collins PY, Holman AR, Freeman MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS. 2006;20(12):1571–82.CrossRefPubMedPubMedCentral Collins PY, Holman AR, Freeman MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS. 2006;20(12):1571–82.CrossRefPubMedPubMedCentral
10.
go back to reference Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.CrossRefPubMed Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.CrossRefPubMed
11.
go back to reference Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43.CrossRefPubMedPubMedCentral Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43.CrossRefPubMedPubMedCentral
12.
go back to reference Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):702–21.CrossRef Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35(3):702–21.CrossRef
13.
go back to reference Almeida SM. Cognitive impairment and major depressive disorder in HIV infection and cerebrospinal fluid biomarkers. Arq Neuropsiquiatr. 2013;71(9B):689–92.CrossRefPubMed Almeida SM. Cognitive impairment and major depressive disorder in HIV infection and cerebrospinal fluid biomarkers. Arq Neuropsiquiatr. 2013;71(9B):689–92.CrossRefPubMed
14.
go back to reference Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22(4):370–9.CrossRefPubMed Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22(4):370–9.CrossRefPubMed
15.
go back to reference Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–86.CrossRefPubMed Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–86.CrossRefPubMed
16.
go back to reference Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–57.CrossRefPubMed Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–57.CrossRefPubMed
17.
go back to reference Kinyanda E, Weiss HA, Levin J, Nakasujja N, Birabwa H, Nakku J, et al. Incidence and persistence of major depressive disorder among people living with HIV in Uganda. AIDS Behav. 2017;21(6):1641–54.CrossRefPubMed Kinyanda E, Weiss HA, Levin J, Nakasujja N, Birabwa H, Nakku J, et al. Incidence and persistence of major depressive disorder among people living with HIV in Uganda. AIDS Behav. 2017;21(6):1641–54.CrossRefPubMed
19.
go back to reference Kinyanda E, Waswa L, Baisley K, Maher D. Prevalence of severe mental distress and its correlates in a population-based study in rural south-west Uganda. BMC Psychiatry. 2011;11:97.CrossRefPubMedPubMedCentral Kinyanda E, Waswa L, Baisley K, Maher D. Prevalence of severe mental distress and its correlates in a population-based study in rural south-west Uganda. BMC Psychiatry. 2011;11:97.CrossRefPubMedPubMedCentral
20.
go back to reference Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.PubMed Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.PubMed
21.
go back to reference Warriner EM, Rourke SB, Rourke BP, Rubenstein S, Millikin C, Buchanan L, et al. Immune activation and neuropsychiatric symptoms in HIV infection. J Neuropsychiatry Clin Neurosci. 2010;22(3):321–8.CrossRefPubMed Warriner EM, Rourke SB, Rourke BP, Rubenstein S, Millikin C, Buchanan L, et al. Immune activation and neuropsychiatric symptoms in HIV infection. J Neuropsychiatry Clin Neurosci. 2010;22(3):321–8.CrossRefPubMed
22.
go back to reference Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001;158(8):1252–7.CrossRefPubMed Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001;158(8):1252–7.CrossRefPubMed
23.
go back to reference Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab. 2005;90(5):2522–30.CrossRefPubMed Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab. 2005;90(5):2522–30.CrossRefPubMed
24.
go back to reference Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MM. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14(1):103–7.CrossRefPubMed Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MM. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14(1):103–7.CrossRefPubMed
25.
go back to reference Song BM, Lee JM, Choi LW, Youm Y, Chu SH, Park YR, et al. Association between C reactive protein level and depressive symptoms in an elderly Korean population: Korean social life, health and aging project. BMJ Open. 2015;5(2):e006429.CrossRefPubMedPubMedCentral Song BM, Lee JM, Choi LW, Youm Y, Chu SH, Park YR, et al. Association between C reactive protein level and depressive symptoms in an elderly Korean population: Korean social life, health and aging project. BMJ Open. 2015;5(2):e006429.CrossRefPubMedPubMedCentral
26.
go back to reference Morris AA, Zhao L, Ahmed Y, Stoyanova N, De Staercke C, Hooper WC, et al. Association between depression and inflammation--differences by race and sex: the META-health study. Psychosom Med. 2011;73(6):462–8.CrossRefPubMedPubMedCentral Morris AA, Zhao L, Ahmed Y, Stoyanova N, De Staercke C, Hooper WC, et al. Association between depression and inflammation--differences by race and sex: the META-health study. Psychosom Med. 2011;73(6):462–8.CrossRefPubMedPubMedCentral
27.
go back to reference Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 2002;90(12):1279–83.CrossRefPubMed Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 2002;90(12):1279–83.CrossRefPubMed
28.
go back to reference Pan A, Ye X, Franco OH, Li H, Yu Z, Wang J, et al. The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS One. 2008;3(1):e1392.CrossRefPubMedPubMedCentral Pan A, Ye X, Franco OH, Li H, Yu Z, Wang J, et al. The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS One. 2008;3(1):e1392.CrossRefPubMedPubMedCentral
Metadata
Title
Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda
Authors
Kenneth Musinguzi
Andrew Obuku
Noeline Nakasujja
Harriet Birabwa
Juliet Nakku
Jonathan Levin
Eugene Kinyanda
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2018
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/s12865-017-0239-3

Other articles of this Issue 1/2018

BMC Immunology 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.